Nature Medicine 25, no. 7 (июль 2019): 1096–1103, doi: 10.1038/s415910190495-2.
36. Zhou, “Strategies,” 194–201.
37. Robert Caesar et al., “Crosstalk between Gut Microbes and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling,” Cell Metabolism 22, no. 4 (6 октября 2015): 658–668, doi: 10.1016/j.cmet.2015.07.026.
38. Ceren Özkul, Meltem Yalınay, and Tarkan Karakan, “Islamic Fasting Leads to an Increased Abundance of Akkermansia muciniphila and Bacteroides fragilis Group: A Preliminary Study on Intermittent Fasting,” Turkish Journal of Gastroenterology 30, no. 12 (декабрь 2019): 1030–1035, doi: 10.5152/tjg.2019.19185.
39. Naito, “A Nextgeneration Beneficial Microbe,” 33–35.
40. Olusegun V. Oyetayo, “Medicinal Uses of Mushrooms in Nigeria: Towards Full and Sustainable Exploitation,” African Journal of Traditional, Complementary and Alternative Medicines 8, no. 3 (2011): 267–274, doi: 10.4314/ajtcam.v8i3.65289.
41. Amy O’Callaghan and Douwe van Sinderen, “Bifidobacteria and Their Role as Members of the Human Gut Microbes,” Frontiers in Microbiology 7 (2016): 925, doi: 10.3389 /fmicb.2016.00925.
42. Audrey Rivière et al., “Bifidobacteria and ButyrateProducing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut,” Frontiers in Microbiology 7 (28 июня 2016): 979, doi: 10.3389/fmicb.2016.00979.
43. Sabrina Duranti et al., “Exploring the Ecology of Bifidobacteria and Their Genetic Adaptation to the Mammalian Gut,” Microorganisms 9, no. 1 (январь 2021): 8, doi: 10.3390 /microorganisms9010008.
44. Rivière, “Bifidobacteria,” 979.
45. O’Callaghan, “Bifidobacteria,” 925.
46. Timur Liwinski et al., “A DiseaseSpecific Decline of the Relative Abundance of Bifidobacterium in Patients with Autoimmune Hepatitis,” Alimentary Pharmacology & Therapeutics 51, no. 12 (июнь 2020): 1417–1428, doi: 10.1111/apt.15754.
47. Flávia Martinello, Camila Fontana Roman, and Paula Alves de Souza, “Effects of Probiotic Intake on Intestinal Bifidobacteria of Celiac Patients,” Arquivos de Gastroenterologia 54, no. 2 (апрель – июнь 2017): 85–90, https://pubmed.ncbi.nlm.nih.gov/28273274/.
48. Helioswilton SalesCampos, Siomar Castro Soares, and Carlo José Freire Oliveira, “An Introduction of the Role of Probiotics in Human Infections and Autoimmune Diseases,” Critical Reviews in Microbiology 45, no. 4 (август 2019): 423–432, doi: 10.1590 /S00042803.201700000-07.
49. Li-Hao Cheng et al., “Psychobiotics in Mental Health, Neurodegenerative and Neurodevelopmental Disorders,” Journal of Food and Drug Analysis 27, no. 3 (июль 2019): 632–648, doi: 10.1016/j.jfda.2019.01.002.
50. O’Callaghan, “Bifidobacteria,” 925.
51. Hend Elsaghir and Anil Reddivari, “Bacteroides Fragilis,” in StatPearls [Internet] (Treasure Island, FL: StatPearls Publishing, 2022), https://pubmed.ncbi.nlm.nih.gov/31971708/.
52. Ezequiel Valguarnera and Juliane Wardenburg, “Good Gone Bad: One Toxin Away from Disease for Bacteroides fragilis,” Journal of Molecular Biology 432, no. 4 (14 февраля 2020): 765–785, doi: 10.1016/j.jmb.2019.12.003.
53. Hannah M. Wexler, “Bacteroides: The Good, the Bad, and the NittyGritty,” Clinical Microbiology Reviews 20, no. 4 (октябрь 2007): 593–621, doi: 10.1128/CMR.00008-07.
54. Amanda Jacobson et al., “A Gut CommensalProduced Metabolite Mediates Colonization Resistance to Salmonella Infection,” Cell Host & Microbe 24, no. 2 (август 2018): 296–307.e7, doi: 10.1016/j.chom.2018.07.002.
55. Helle Krogh Pedersen, “Human Gut Microbes Impact Host Serum Metabolome and Insulin Sensitivity,” Nature 535, no. 7612 (21 июня 2016): 376–381, doi: 10.1038/nature18646.
56. Alf A. Lindberg et al., “Structureactivity Relationships in Lipopolysaccharides of Bacteroides Fragilis,” Research and Reviews of Infectious Diseases 12, suppl. 2 (январь-февраль 1990): 133–141, doi: 10.1093/clinids/12.supplement_2.s133.
57. Diogo Costa et al., “Human Microbiota and Breast Cancer— Is There Any Relevant Link? – A Literature Review and New Horizons Toward Personalized Medicine,” Frontiers in Microbiology 12 (25 февраля 2021): 584332, doi: 10.3389/fmicb.2021.584332.
58. D.H Kim and Y.H. Jin, “Intestinal Bacterial Betaglucuronidase Activity of Patients with Colon Cancer,” Archives of Pharmacal Research 24, no. 6 (декабрь 2001): 564–567, doi: 10.1007/BF02975166.
59. Knip, “The Role of the Intestinal Microbiota,” 154–167.
60. R.T. Krawczyk and A. Banaszkiewicz, “Dr. Józef Brudziński— the True ‘Father of Probiotics’,” Beneficial Microbes 12, no. 3 (15 июня 2021): 211–213, doi: 10.3920/BM2020.0201.
61. Laura Marin et al., “Bioavailability of Dietary Polyphenols and Gut Microbes Metabolism: Antimicrobial Properties,” BioMed Research International 2015, no. 905215 (23 февраля 2015), doi: 10.1155/2015/905215.
62. Rebecca L. Fine, Derek L. Mubiru, and Martin A. Kriegel, Advances in Immunology 146 (2020): 29–56, doi: 10.1016/bs.ai.2020.02.002.
63. V. Buchta, “Vaginal Microbiome,” Ceska Gynekologie 83, no. 5 (2018): 371–379, https:// pubmed.ncbi.nlm.nih.gov/30848142/.
64. José Matos et al., “Insights from Bacteroides Species in Children with Type 1 Diabetes,” Microorganisms 9, no. 7 (2 июля 2021): 1436, 10.3390/microorganisms9071436.
65. Lin, “Abnormal Intestinal Permeability,” 5153–5160.
66. Alok K. Paul et al., “Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus,” Microorganisms 9, no. 5 (16 мая 2021): 1070, doi: 10.3390/microorganisms9051070.
67. Douglas J. Morrison and Tom Preston, “Formation of ShortChain Fatty Acids by the Gut Microbes and Their Impact on Human Metabolism,” Gut 7, no. 3 (2016): 189–200, doi: 10.1080/19490976.2015.1134082.
68. Eva C. SotoMartin et al., “Vitamin Biosynthesis by Human Gut ButyrateProducing Bacteria and CrossFeeding in Synthetic Microbial Communities,” mBio 11, no. 4 (июль-август 2020): e00886-20, doi: 10.1128/mBio.00886-20.
69. Alison M. Stephen and J.H. Cummings, “The Microbial Contribution to Human Faecal Mass,” Journal of Medical Microbiology 13, no. 1 (1 февраля 1980), doi: 10.1099/00222615-13-1-45.
70. Maria Sanchez and Premysl Bercik, “Epidemiology and Burden of Chronic Constipation,” Canadian Journal of Gastroenterology 25, suppl. B (октябрь 2011): 11B–15B, doi: 10.1155/2011/974573.
71. Francesco Asnicar et al., “Blue Poo: Impact of Gut Transit Time on the Gut Microbiome Using a Novel Marker,” Gut 70 (2021): 1665–1674, doi: 10.1136/gutjnl2020323877.
72. Tuwilika P.T. Keendjele et al., “Corn? When Did I Eat Corn? Gastrointestinal Transit Time in Health Science Students,” Advances in Physiology Education 45, no. 1 (1 марта 2021): 103–108, doi: 10.1152/advan.00192.2020.
73. Satish S.C. Rao et al., “Evaluation of Gastrointestinal Transit in Clinical Practice: Position Paper of the American and European Neurogastroenterology and Motility Societies,” Neurogastroen terology & Motility 23, no. 1 (7 декабря 2010): 8–23, doi: 10.1111/j.13652982.2010.01612.x.
74. Stephen J. Lewis and Ken W. Heaton, “Stool Form Scale as a Useful Guide to Intestinal Transit Time,” Scandinavian Journal of Gastroenterology 32, no. 9 (1997): 920–924, doi: 10.3109/00365529709011203.
75. Jan Bures et al., “Small Intestinal Bacterial Overgrowth Syndrome,” World Journal of Gastroenterology 16, no. 24 (28 июня 2010): 2978–2990, doi: 10.3748/wjg.v16.i24.2978.
76. Asnicar, “Blue Poo,” 1665–1674.
77. Asnicar, “Blue Poo,” 1665–1674.
78. Chin Wai Ho, “Varieties, Production, Composition and Health Benefits of Vinegars: A Review,” Food Chemistry 221 (15 апреля 2017): 1621–1630, doi: 10.1016/j.foodchem.2016.10.128.
79. Darshna Yagnik, Vlad Serafin, and Ajit J. Shah, “Antimicrobial Activity of Apple Cider Vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; Downregulating Cytokine and Microbial Protein Expression,” Scientific Reports 8 (2018): 1732, doi: 10.1038 /s4159801718618-x.
80. KengLiang Wu et al., “Effects of Ginger on Gastric Emptying and Motility in Healthy Humans,” European Journal of Gastroenterology and Hepatology 20, no. 5 (май 2008): 436–440, doi: 10.1097/MEG.0b013e3282f4b224.
81. Edzard Ernst and Max H. Pittler, “Efficacy of Ginger for Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials,” British Journal of Anaesthesia 84, no. 3 (2000): 367–371, https://www.ncbi.nlm.nih.gov/books/NBK68168/.
82. Fumiko Higashikawa, “Improvement of Constipation and Liver Function by Plantderived Lactic Acid Bacteria: A Doubleblind, Randomized Trial,” Nutrition 26, no. 4 (апрель 2010): 367–374, doi: 10.1016/j.nut.2009.05.008.
83. Angela Saviano et al., “Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?”, Medicina 57, no. 7 (23 июня 2021): 643, doi: 10.3390/medicina57070643.
1. Francis Coucke, “Food Intolerance in Patients with Manifest Autoimmunity: Observational Study,” Autoimmunity Reviews Volume 17, Issue 11, (2018): 1078–1080, doi: 10.1016/j.autrev.2018.05.011.
2. M. Hvatum et al., “The GutJoint Axis: Cross Reactive Food Antibodies in Rheumatoid Arthritis,” Gut 55, no. 9 (сентябрь 2006), http://dx.doi.org/10.1136/gut.2005.076901.
3. Giuseppe Losurdo et al., “Extraintestinal Manifestations of NonCeliac Gluten Sensitivity: An Expanding Paradigm,” World Journal of Gastroenterology 24, no. 14 (14 апреля 2018): 1521–1530, doi: 10.3748/wjg.v24.i14.1521.